Jamie Dananberg - 14 Dec 2021 Form 4 Insider Report for Unity Biotechnology, Inc. (UBX)

Role
Chief Medical Officer
Signature
/s/ Alexander Nguyen, Attorney-in-Fact for Jamie Dananberg
Issuer symbol
UBX
Transactions as of
14 Dec 2021
Net transactions value
-$17,301
Form type
4
Filing time
15 Dec 2021, 15:26:55 UTC
Previous filing
01 Oct 2021
Next filing
15 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UBX Common Stock, $0.0001 par value Tax liability $17,301 -10,614 -1.6% $1.63 659,697 14 Dec 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold by the Reporting Person pursuant to a Rule 10b5-1 trading plan to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
F2 Includes Restricted Stock Units which vest over time measured from the grant date.